T1 Tenor

The heat is unbearable in some parts, not only in the environment, but also hopefully the heat directed at the decision-makers in 'non-compliant' CCGs who are either refusing to accept that Libre is a revolutionary tool for many T1s or have agreed to fund, but then set crippling criteria. Latest Prescribing Data Progress in prescribing continues, with stabilisation in Scotland and a continuation of the steady rise in the other three countries of the UK.  The Wales May data should be out this week. As mentioned last month, the situation in Scotland is particularly promising and the excellent Edinburgh Centre for Endocrinology and the Scottish Health Technologies Group have published documents that should significantly help the Libre case.  These documents are based on the first six months of prescribing Libre. Healthcare Improvement Scotland Statement Flash Glucose Monitoring is associated with improved glycaemic control and quality of life in people with type 1 ...

June Update & Miaomiao (Libre CGM-enabler) Libre Funding - Data to end of April Funding for Libre continues to ebb and flow with some great advances, some significant let-downs and plenty of fence sitting.  I have taken a special interest in three areas.  Birmingham/Solihull CCG (because it's where I live and is the largest CCG), Bristol, North Somerset, South Gloucestershire CCG (because it's the second biggest, people from our Facebook group have set up a separate pressure group and because their decision is similarly flawed to the Birmingham decision), and South Warwickshire (as their decision to fund with a ridiculous criteria, whose only logic is to stop anybody actually meeting the criteria set!). So, to update the current prescribing situation - note Scotland - more later! The situation is Scotland is being driven by the Edinburgh Centre for Endocrinology & Diabetes led by Dr Fraser Gibb .  They are being innovative both how they are initiatin...